Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in JNJ — Johnson & Johnson

CIK 1000275 TORONTO, A6
Back to JNJ Full portfolio

Position in JNJ

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,355,318,297
+$82,901,762 QoQ
Shares Held
13,211,475
-1.3% QoQ
Ownership
0.548%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#28
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 97% Shared 1% None 2%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Derivatives in JNJ

reported options exposure · as of Jun 30, 2026
CallValue
$324,446,675
CallShares
1,277,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $19,128,320,487 across 19 Drug Manufacturers - General names. JNJ ranks #2 (17.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 4,358,401 $5,227,597,337
2 JNJ
Johnson & Johnson
This page 		13,211,475 $3,355,318,297
3 ABBV
AbbVie Inc.
 8,163,806 $2,054,340,133
4 AZN
Astrazeneca PLC
 10,427,503 $1,977,263,112
5 MRK
Merck & Co., Inc.
 14,293,086 $1,836,661,547
6 AMGN
Amgen Inc
 4,328,785 $1,567,539,618
7 PFE
Pfizer Inc
 32,814,260 $790,167,373
8 BMY
Bristol Myers Squibb Co
 12,094,886 $696,907,326

All Filings in JNJ

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,355,318,297 13,211,475
2026-06-30 $324,446,675 1,277,500
2026-03-31 $152,775,000 625,000
2026-03-31 $3,272,416,535 13,387,402
2025-12-31 $2,956,810,740 14,287,561
2025-12-31 $107,614,000 520,000
2025-09-30 $2,632,023,171 14,194,926
2025-09-30 $107,691,936 580,800
2025-06-30 $77,902,500 510,000
2025-06-30 $2,175,028,020 14,239,136
2025-03-31 $2,479,267,193 14,949,754
2025-03-31 $127,696,800 770,000
2024-12-31 $2,169,300 15,000
2024-12-31 $2,081,749,936 14,394,620
2024-12-31 $86,772 600
2024-09-30 $2,657,784 16,400
2024-09-30 $2,426,468,949 14,972,658
2024-06-30 $2,151,133,178 14,717,660
2024-06-30 $3,157,056 21,600
2024-03-31 $2,096,066,688 13,250,311
2024-03-31 $2,372,850 15,000
2023-12-31 $2,105,492,487 13,433,026
2023-12-31 $9,404,400 60,000
2023-12-31 $31,316,652 199,800
2023-09-30 $31,118,850 199,800
2023-09-30 $9,345,000 60,000
2023-09-30 $1,933,618,488 12,414,886
2023-06-30 $33,104,000 200,000
2023-06-30 $2,482,800 15,000
2023-06-30 $2,273,003,059 13,732,498
2023-03-31 $2,072,505,310 13,371,002
2023-03-31 $27,280,000 176,000
2022-12-31 $6,182,750 35,000
2022-12-31 $39,746,250 225,000
2022-12-31 $2,557,941,102 14,480,278
2022-09-30 $8,168,000 50,000
2022-09-30 $2,209,084,274 13,522,798
2022-06-30 $2,401,878,926 13,530,950
2022-03-31 $2,516,183,217 14,197,276
2022-03-31 $176,095,728 993,600
2021-12-31 $2,903,265,400 16,971,213
2021-12-31 $90,034,141 526,300
2021-09-30 $2,698,488,476 16,708,907
2021-09-30 $71,867,500 445,000
2021-06-30 $2,799,258,283 16,991,977
2021-03-31 $2,556,307,451 15,554,046
2021-03-31 $16,435,000 100,000
2020-12-31 $3,226,290 20,500
2020-12-31 $2,660,047,611 16,902,069
2020-09-30 $2,977,600 20,000

Report a Problem

Category
Description
Email (optional, for follow-up)